Skip to main content
. 2020 Jul 5;2020:1236520. doi: 10.1155/2020/1236520

Table 1.

Detailed characteristics of COVID-19 patients who developed cutaneous manifestations.

Cutaneous manifestation Number of patients Age (years) Sex Country Localization of the skin lesions Dermatological symptoms Phase of COVID-19 in which skin lesions appeared Clinical course of the skin lesions Taking any medication before the appearance of skin lesions Method of COVID-19 diagnosis
Maculopapular rash 14 [6] N/M N/M Italy Mainly trunk Mild itching or asymptomatic Active phase Resolved few days later N/M All cases were confirmed by PCR.
1 [11] 64 F France Trunk & flexors N/M Active phase Resolved 5 days later without any treatment Paracetamol for 4 days (but the cutaneous lesions disappeared despite the drug was not discontinued) PCR
1 [12] 59 F Italy Trunk & limbs N/M Active phase in ICU Resolved 5 days later without any treatment N/M PCR
1 [12] 89 F Italy Trunk & limbs N/M Active phase in ICU Resolved 8 days later without any treatment N/M PCR
1 [12] 57 M Italy Generalized Itching Prodromal phase Reduced 10 days later, after taking levofloxacin and hydroxychloroquine N/M PCR
2 [13] N/M N/M France Face & upper body Itching Active phase Resolved a few days later N/M Both cases were confirmed by PCR.
1 [14] 58 M USA Trunk & extremities Itching Active phase Began to improve 3 days later without any treatment Azithromycin+benzonatate PCR
1 [15] 20 M USA Generalized, sparing the face N/M Active phase N/M N/M PCR
1 [16] 6 M Thailand Generalized Itching Active phase Resolved 5 days later without any treatment No medication PCR
1 [9] 57 F France Trunk & limbs Asymptomatic except for burning sensation of palms Active phase Resolved 9 days later without any treatment Paracetamol PCR
176 [17] Mean age: 55.3 F: 98
M: 78
Spain N/M Asymptomatic: 64
Pain: 4
Burning: 9
Itching: 99
Prodromal phase: 8
Active phase: 108
Convalescence phase: 60
Resolved few days later (mean: 8.6 days) N/M 122 cases were confirmed by PCR. Others were not tested.
Urticaria 3 [6] N/M N/M Italy Mainly trunk Mild itching or asymptomatic Active phase Resolved few days later N/M PCR
1 [18] 32 F Spain Generalized Itching Active phase Resolved 5 days later after taking antihistamines Azithromycin+hydroquinone N/M
1 [19] 27 F France Face & acral parts Itching Prodromal phase Slow improvement after taking antihistamines No medication PCR
2 [6] N/M N/M France Face & upper body Itching Active phase: 1
Prodromal phase: 1
Resolved a few days later N/M Both cases were confirmed by PCR.
1 [20] 71 M Belgium Generalized Asymptomatic Active phase Resolved a few days later after taking bilastine No new medication All cases were confirmed by PCR.
1 [20] 39 F Belgium Generalized Itching Active phase Resolved a few days later after taking bilastine No medication N/M
1 [16] 2 months F Thailand Generalized except for palms & soles Itching Active phase Resolved 9 days later without any treatment No medication PCR
1 [21] 37 F Italy Trunk, neck & face Asymptomatic Active phase (10th postpartum day) Resolved 8 days later without any treatment Acetaminophen N/M
73 [17] Mean age: 48.7 F: 47
M: 26
Spain N/M Asymptomatic: 4
Pain: 1
Burning: 1
Itching: 67
Prodromal phase: 3
Active phase: 43
Convalescence phase: 25
Resolved few days later (mean: 12.7 days) N/M 49 cases were confirmed by PCR. Others were not tested.
Chilblain 1 [22] 27 F Kuwait Dorsal aspect of fingers Asymptomatic Asymptomatic for COVID-19 N/M No medication/no exposure to cold PCR
1 [22] 35 F Kuwait Dorsal aspect of fingers Asymptomatic Asymptomatic for COVID-19 N/M No medication/no exposure to cold PCR
3 [13] 14-22 N/M France Toes of both feet Pain and burning Asymptomatic for COVID-19 N/M No medication/no exposure to cold Not tested
1 [15] 28 F Spain Both heels Itching Active phase N/M No medication/no exposure to cold N/M
1 [23] 26 M Italy Both heels Asymptomatic Asymptomatic for COVID-19 N/M No medication/no exposure to cold Not tested
1 [23] 16 F Italy Both heels Asymptomatic Asymptomatic for COVID-19 except for pharyngodynia 2 weeks ago N/M No medication/no exposure to cold Not tested
1 [23] 18 F Italy Both heels & extensor surfaces of toes Asymptomatic Asymptomatic for COVID-19 N/M No medication/no exposure to cold Not tested
1 [23] 48 M Italy Extensor surfaces of both heels N/M Active phase N/M No medication/no exposure to cold Not tested
Vesicular rash 22 [24] Median age = 60 M (16 cases)
F (6 cases)
Italy All had truncal lesions ± involvement of extremities Mild itching in 9 cases Active phase Resolved 4-15 days later No medication All cases were confirmed by PCR.
1 [6] N/M N/M Italy Mainly trunk N/M Active phase Resolved few days later N/M PCR
1 [25] 8 F Italy Trunk Asymptomatic Active phase Resolved 7 days later without any treatment No medication PCR
2 [7] N/M N/M Italy Trunk (localized herpetiform) Mild itching Active phase N/M N/M N/M
1 [7] N/M N/M Spain Back (localized herpetiform) N/M Active phase N/M N/M N/M
34 [15] Mean: 45.6 F: 19
M: 15
Spain N/M Asymptomatic: 6
Pain: 3
Burning: 2
Itching: 23
Prodromal phase: 5
Active phase: 19
Convalescence phase: 10
Resolved few days later (mean: 9.3 days) N/M 17 cases were confirmed by PCR. Others were not tested.
Livedo reticularis 1 [25] 67 M USA Anterior thigh Asymptomatic Active phase Resolved 19 hours later without any treatment N/M PCR
1 [25] 47 F USA Right lower limb Asymptomatic Convalescence phase Resolved 20 minutes later without any treatment No medication but appeared after sun exposure PCR
21 [25] Mean age: 63.1 F: 10
M: 11
Spain N/M Asymptomatic: 15
Pain: 1
Burning: 2
Itching: 3
Prodromal phase: 1
Active phase: 18
Convalescence phase: 2
Resolved few days later (mean: 9.4 days) N/M 17 cases were confirmed by PCR. Others were not tested.
Petechiae 1 [26] N/M N/M Thailand N/M N/M Prodromal phase N/M N/M PCR
1 [14] 48 M Spain Buttocks, popliteal fossa, proximal anterior thighs, lower abdomen Itching Active phase Resolved 5 days later with 0.05% betamethasone cream+loratadine No new medication PCR

M: male; F: female; N/M: not mentioned; PCR: polymerase chain reaction; ICU: intensive care unit.